Myriad Genetics Inc (NASDAQ:MYGN)

18.65
Delayed Data
As of 3:59pm ET
 +1.01 / +5.73%
Today’s Change
9.24
Today|||52-Week Range
30.13
-31.51%
Year-to-Date
No recent news for Myriad Genetics Inc.

Today’s Trading

Previous close17.64
Today’s open17.83
Day’s range17.60 - 18.80
Volume35,662
Average volume (3 months)696,479
Market cap$1.3B
Data as of 3:59pm ET, 11/24/2020

Growth & Valuation

Earnings growth (last year)-4,389.30%
Earnings growth (this year)--
Earnings growth (next 5 years)-27.41%
Revenue growth (last year)-24.97%
P/E ratioNM
Price/Sales1.32
Price/Book1.40

Competitors

 Today’s
change
Today’s
% change
LNTHLantheus Holdings In...+0.38+2.95%
VIVOMeridian Bioscience ...-0.28-1.59%
TRILTrillium Therapeutic...-0.26-1.47%
CLDXCelldex Therapeutics...+0.97+4.56%
Data as of 3:59pm ET, 11/24/2020

Financials

Last reporting date--
EPS forecast (this quarter)$0.03
Annual revenue (last year)$638.6M
Annual profit (last year)-$199.5M
Net profit margin-31.24%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Salt Lake City, Utah

Forecasts